BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, June 30, 2026
Home » Topics » Disease categories and therapies » Orthopedics

Orthopedics
Orthopedics RSS Feed RSS

Robotic and human hands touching computer screen

Rsip Vision releases joint segmentation tool for revision arthroplasty and other orthopedic procedures

March 24, 2021
By David Ho
HONG KONG – Israel and U.S.-based Rsip Vision Ltd. unveiled an advanced joint segmentation tool to assist with the planning of revision arthroplasty and other orthopedic procedures for patients with pre-existing metal implants. The detailed, noninvasive artificial intelligence (AI)-based software module enables quick and accurate segmentation of different joints from CT scans of hips, knees, shoulder and spines.
Read More

BioWorld MedTech’s Orthopedics Extra for March 24, 2021

March 24, 2021
By Holland Johnson
Keeping you up to date on recent developments in orthopedics, including: TKR a cost-effective treatment for patients with knee osteoarthritis; Nonsurgical treatment quickly reduces arthritis knee pain and improves function; Inflammation and pressure-sensing leads to 'feed-forward' loop in osteoarthritis.
Read More
Surgical system in use

Seaspine inks deal to acquire 7D Surgical for $110M

March 23, 2021
By Annette Boyle
Thirteen months after establishing a strategic alliance to distribute 7D Surgical Inc.’s machine-vision, image-guided surgery platform, Seaspine Holdings Corp. (NASDAQ:SPNE) signed an agreement to acquire the Toronto-based company. 7D Surgical shareholders will receive $27.5 million in cash plus $82.5 million in Seaspine stock and will hold approximately 13% of Seaspine’s shares at completion. The deal is expected to close in the second quarter of 2021.
Read More

BioWorld MedTech’s Orthopedics Extra for March 17, 2021

March 17, 2021
By Holland Johnson
Keeping you up to date on recent developments in orthopedics, including: Examining the value of lumbar spine surgery; Hip fracture outcomes worse during busy periods; Predicting the likelihood of bone fractures in older men.
Read More

BioWorld MedTech’s Orthopedics Extra for March 10, 2021

March 10, 2021
By Holland Johnson
Keeping you up to date on recent developments in orthopedics, including: Injectable porous scaffolds promote better, quicker healing after spinal cord injuries; Researchers grow most lifelike bone yet from woven cells; Rapid 3D printing method moves toward 3D-printed organs; Study links kidney stones with bone problems.
Read More

BioWorld MedTech’s Orthopedics Extra for March 3, 2021

March 3, 2021
By Holland Johnson
Keeping you up to date on recent developments in orthopedics, including: Treating rheumatoid arthritis with micromotors; Bioengineered hybrid muscle fiber for regenerative medicine; Immunosuppressive cell and cytokine response linked to bone nonunion.
Read More

BioWorld MedTech’s Orthopedics Extra for Feb. 24, 2021

Feb. 24, 2021
By Holland Johnson
Keeping you up to date on recent developments in orthopedics, including: Scientists repair injured spinal cord using patients' own stem cells; ALS neuron damage reversed with new compound; Nexus Spine reports availability of implants for spine surgery.
Read More
Product image

Brainlab wins FDA nod for mobile imaging robot, surgical alignment tool

Feb. 22, 2021
By Meg Bryant
The U.S. FDA has given a green light to Brainlab AG for two new additions to its robotic surgery systems. The agency granted 510(k) clearances for the Loop-X mobile imaging robot and the Cirq Robotic Alignment module for spine procedures, paving the way for U.S. market entry.
Read More

BioWorld MedTech’s Orthopedics Extra for Feb. 17, 2021

Feb. 17, 2021
By Holland Johnson
Keeping you up to date on recent developments in orthopedics, including: Radioactive bone cement may be safer in treating spinal tumors; Unlocking the mystery behind skeletal aging; Sweet coating for sour bones.
Read More
Device image

Blue Ocean Spine wins investment backing from SHS

Feb. 16, 2021
By Bernard Banga
Blue Ocean Spine GmbH has won a major investment from SHS GmbH, also from Tuttlingen in Germany, to develop its next-generation functional spinal implant. The two companies are declining to disclose the size of the series A investment.
Read More
Previous 1 2 … 13 14 15 16 17 18 19 20 21 … 29 30 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 29, 2026.
  • Illustration for mutations in the DNA leading to brain diseases or neurodegenerative disorders

    ENCALS 2026: From genetics to advancing strategies against ALS

    BioWorld Science
    Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
  • Handshake with DNA, molecules

    Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement

    BioWorld Science
    Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
  • Digital brain with dollar sign

    Investors bet on transformative BCI tech for neuro disorders

    BioWorld
    An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....
  • Shanghai Yingli Pharmaceutical identifies new KRAS mutant inhibitors

    BioWorld Science
    Shanghai Yingli Pharmaceutical Co. Ltd. has discovered hydrazine-structured compounds as inhibitors of GTPase KRAS and its mutants. They are reported to be useful...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing